Literature DB >> 16350405

The cottontail rabbit papillomavirus model of high-risk HPV-induced disease.

Janet L Brandsma1.   

Abstract

Animal models are essential to study the pathogenesis of papillomavirus infection and develop strategies for treatment and prevention. This review details use of the cottontail rabbit papillomavirus (CRPV)-laboratory rabbit model. The protocols describe how to infect rabbits with CRPV DNA or CRPV virus to induce papillomas. They also describe the design and analysis of genetic pathogenesis experiments, prophylactic and therapeutic intervention experiments, and malignant progression experiments.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16350405     DOI： 10.1385/1-59259-982-6:217

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


  20 in total

1.  Using HLA-A2.1 Transgenic Rabbit Model to Screen and Characterize New HLA-A2.1 Restricted Epitope DNA Vaccines.

Authors:  Jiafen Hu; Todd D Schell; Xuwen Peng; Nancy M Cladel; Karla K Balogh; Neil D Christensen
Journal:  J Vaccines Vaccin       Date:  2010-08-20

2.  Mouse papillomavirus infections spread to cutaneous sites with progression to malignancy.

Authors:  Nancy M Cladel; Lynn R Budgeon; Timothy K Cooper; Karla K Balogh; Neil D Christensen; Roland Myers; Vladimir Majerciak; Deanna Gotte; Zhi-Ming Zheng; Jiafen Hu
Journal:  J Gen Virol       Date:  2017-10       Impact factor: 3.891

3.  Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model.

Authors:  Jiafen Hu; Lynn R Budgeon; Nancy M Cladel; Karla Balogh; Roland Myers; Timothy K Cooper; Neil D Christensen
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

Review 4.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

5.  Establishment of a cottontail rabbit papillomavirus/HLA-A2.1 transgenic rabbit model.

Authors:  Jiafen Hu; Xuwen Peng; Lynn R Budgeon; Nancy M Cladel; Karla K Balogh; Neil D Christensen
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

6.  Reversal of papilloma growth in rabbits therapeutically vaccinated against E6 with naked DNA and/or vesicular stomatitis virus vectors.

Authors:  Janet L Brandsma; Mark Shlyankevich; Yuhua Su; Daniel Zelterman; John K Rose; Linda Buonocore
Journal:  Vaccine       Date:  2009-07-15       Impact factor: 3.641

7.  GS-9191 is a novel topical prodrug of the nucleotide analog 9-(2-phosphonylmethoxyethyl)guanine with antiproliferative activity and possible utility in the treatment of human papillomavirus lesions.

Authors:  Grushenka H I Wolfgang; Riri Shibata; Jianying Wang; Adrian S Ray; Sylvia Wu; Edward Doerrfler; Hans Reiser; William A Lee; Gabriel Birkus; Neil D Christensen; Graciela Andrei; Robert Snoeck
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

8.  Wounding prior to challenge substantially improves infectivity of cottontail rabbit papillomavirus and allows for standardization of infection.

Authors:  Nancy M Cladel; Jiafen Hu; Karla Balogh; Andres Mejia; Neil D Christensen
Journal:  J Virol Methods       Date:  2007-12-03       Impact factor: 2.014

9.  Papillomavirus DNA complementation in vivo.

Authors:  Jiafen Hu; Nancy M Cladel; Lynn Budgeon; Karla K Balogh; Neil D Christensen
Journal:  Virus Res       Date:  2009-04-18       Impact factor: 3.303

10.  Long-peptide therapeutic vaccination against CRPV-induced papillomas in HLA-A2.1 transgenic rabbits.

Authors:  Jiafen Hu; Lynn R Budgeon; Karla K Balogh; Xuwen Peng; Nancy M Cladel; Neil D Christensen
Journal:  Trials Vaccinol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.